Filing metadata

Accession number
0001493152-21-001030
Form type
Form 4
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Jan 14, 2021
Reporting period
Jan 14, 2021
Description
Insider transaction

Explore SEC Filings Hub